World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
13034
World Ranking
11369
National Ranking
202

Christoph Driessen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Christoph Driessen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 218 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Christoph Driessen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Driessen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Christoph Driessen is affiliated with the University of St. Gallen in Switzerland. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, their work delves deeply into subfields including Molecular Biology, Hematology, Oncology, Immunology, and Genetics.

The scientist's main research topics encompass multiple aspects of hematologic cancers and treatment strategies, notably:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Ubiquitin and Proteasome Pathways
  • Peptidase Inhibition and Analysis
  • Immunotherapy and Immune Responses
  • Chronic Lymphocytic Leukemia Research
  • CAR-T Cell Therapy Research

Frequent coauthors working alongside Christoph Driessen include Lenka Bešše, Andrej Bešše, Hermann Einsele, Mario Boccadoro, and Pieter Sonneveld, with collaborative publications ranging from 22 to 38 papers each.

The scientist's publications are regularly featured in several prominent journals, with the highest number of contributions appearing in Blood, followed by Clinical Lymphoma Myeloma & Leukemia, Cancer Research, Leukemia, and HemaSphere.

Selected recent papers authored or coauthored by Christoph Driessen include:

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, 2020, The Lancet Haematology
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, 2021, The Lancet Oncology
  • Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network, 2020, Leukemia
  • Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network, 2023, The Lancet Oncology
  • The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance, 2022, Nature Communications

Best Publications

  • Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

    Jörn Dengjel;Oliver Schoor;Rainer Fischer;Michael Reich

  • Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

    Zdenek Skrott;Martin Mistrik;Klaus Kaae Andersen;Søren Friis

  • Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.

    Shirin Arastu-Kapur;Janet L. Anderl;Marianne Kraus;Francesco Parlati

  • Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.

    Fiamma Berner;David Bomze;Stefan Diem;Omar Hasan Ali

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michele Cavo;Meral Beksac;Lucia Pantani

  • Proteases involved in MHC class II antigen presentation.

    Jose A. Villadangos;Rebecca A. R. Bryant;Jan Deussing;Christoph Driessen

  • Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages

    Guo-Ping Shi;Rebecca A.R. Bryant;Richard Riese;Steven Verhelst

  • Multiple myeloma: patient outcomes in real-world practice.

    Kwee Yong;Michel Delforge;Christoph Driessen;Leah Fink

  • Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells

    Christoph Driessen;Rebecca A.R. Bryant;Ana-Maria Lennon-Duménil;José A. Villadangos

  • European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

    Monika Engelhardt;Evangelos Terpos;Martina Kleber

  • Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)

    Holger Schulz;Ute Rehwald;Franck Morschhauser;Thomas Elter

  • Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

    Christoph Mamot;Dirk Klingbiel;Felicitas Hitz;Christoph Renner

  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

    Philippe Moreau;Shaji K. Kumar;Jesús San Miguel;Faith Davies

  • Treatment of relapsed CD20 + Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group

    Ute Rehwald;Holger Schulz;Marcel Reiser;Markus Sieber

  • Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells.

    T Rückrich;M Kraus;J Gogel;A Beck

  • Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes.

    C Driessen;K Hirv;L Rink;H Kirchner

  • Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis

    Eva Tolosa;Weijie Li;Yoshiyuki Yasuda;Wolfgang Wienhold

  • Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism.

    G P Soriano;L Besse;N Li;M Kraus

  • Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro

    Hermann Beck;Gerold Schwarz;Christian J. Schröter;Martin Deeg

  • Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors.

    Omar Hasan Ali;Fiamma Berner;David Bomze;Mirjam Fässler

Frequent Co-Authors

Herman S. Overkleeft
Herman S. Overkleeft Leiden University
Michele Cavo
Michele Cavo University of Bologna
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Hubert Kalbacher
Hubert Kalbacher University of Tübingen
Heinz Ludwig
Heinz Ludwig University of Vienna
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Roman Hájek
Roman Hájek University of Ostrava
Mario Boccadoro
Mario Boccadoro University of Turin
Hermann Einsele
Hermann Einsele University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens doors to a range of rewarding career and education options in the health and life sciences. If you’re interested in the administrative side of healthcare, the job outlook for medical billing and coding shows promising growth, with strong demand for skilled professionals.

For those seeking flexibility and affordability, consider earning an online health information management degree. This field combines healthcare, business, and technology to support patient care and hospital operations.

Nutrition is another promising pathway. Pursuing the cheapest online master's in nutrition allows you to upskill in nutrition science and opens doors to roles in wellness, clinical practice, and research.

Lastly, hands-on healthcare roles such as sonography are highly regarded and in demand. Accredited online sonography programs are available for those wanting to become ultrasound techs, offering both flexibility and specialized training.

Best Scientists Citing Christoph Driessen

Trending Scientists

Recently Published Articles